Amsterdam-based Tebi Announces €30 Million Investment Led by Alphabet growth fund CapitalG to transform hospitality operations
10.6.2025 15:05:00 CEST | Business Wire | Press release
Investment to accelerate product development, hiring, and global expansion
Tebi, the Amsterdam-based startup developing an all-in-one financial operating system for hospitality, today announced a €30 million investment led by Alphabet independent growth fund CapitalG, with participation from existing investor Index Ventures. This follows Tebi’s €20 million Series A announced just six months ago and brings the company’s total funding to €56 million.
The financing reflects the company’s momentum across product innovation, hiring and expansion into new markets. The investment will support Tebi’s continued growth in these key areas of focus.
The company was founded in 2021 by technical alumni from Adyen, a €45B Dutch company, including serial entrepreneur Arnout Schuijff as CEO and Rob Vonk as CTO. Tebi is the third company co-founded by Schuijff, who previously served as Adyen’s longtime CTO and co-founder.
Aki Tas, former head of business strategy and operations at Notion, joined last fall as COO to lead the product, marketing, and foundation teams, and Patrick Studener, former COO at Wolt (now part of Doordash) and previous head of European expansion at Uber, joined at the beginning of the year as CCO to lead operational teams.
The investment will fuel Tebi's mission to transform operations for hospitality businesses worldwide. Until now, businesses have had to cobble together difficult-to-use solutions that lack key features, handle back-office tasks slowly and manually, and make it difficult to assess business performance. Tebi is rethinking hospitality technology from the ground-up, unifying the point of sale, payments, inventory management, a kitchen display system, reservations, and QR ordering functionality through an intuitive, mobile-first platform built on an accounting backbone. By being built around the point of sale, Tebi can coordinate both operations and finances for complex hospitality businesses. AI-enabled onboarding enables businesses to get started quickly, while the comprehensive platform simplifies and unifies workflows and makes key business metrics easily viewable.
Merchants across the Netherlands are already processing nine figures of payments annually on the platform. With this new investment, Tebi plans to accelerate product development, expand its reach globally, and grow its team. Beginning today, Tebi will also begin serving the UK market, marking the beginning of a broader global expansion strategy (UK customers can find Tebi at tebi.com/gb/).
"Hospitality businesses are the lifeblood of our communities, yet they've been underserved by technology, especially here in Europe," said Arnout Schuijff, co-founder and CEO of Tebi. "No one opens a restaurant or store because they love paperwork and integrating tools; they do it for the passion of serving people. It’s a privilege to build a world-class team devoted to empowering European business owners to free up time to focus on the craft and customers they cherish.”
“We are thrilled to partner with Tebi as they build the operating system for hospitality businesses,” said Alex Nichols, Partner at CapitalG. “Even though most small business front and back office workflows revolve around payments, three-quarters of Europe’s SMB payments are disconnected from software. By unifying these disjointed systems, Tebi is bringing greater efficiency and visibility to small business owners’ daily work. Arnout and his team combine focused customer centricity, speed, and unique founder-market fit. We couldn’t imagine a better team to pursue this massive opportunity.”
"Moving from disconnected systems – our previous POS software, a separate reservations platform, paper kitchen tickets, and a standalone payments provider – to Tebi's single integrated platform led us to embrace a new mindset at Zoldering. We approached it as if we were starting fresh, letting go of old habits to realize a seamless workflow from reservation to service to kitchen. Tebi has not just replaced our old systems; it has enabled a new way of working by unifying our data, streamlining communication between front and back of house, and offering the flexibility to adapt workflows to our specific needs – exactly what's required to maintain the standards expected of a Michelin-starred restaurant,” said Tomas and Job from Zoldering.
Tebi currently employs 35 people and is planning to double its headcount by the end of the year with roles open in Amsterdam and London.
About Tebi
Tebi is an all-in-one financial operating system for independent hospitality businesses. Founded in 2021, Tebi provides a comprehensive, mobile-first solution that includes point of sale, integrated payments, a kitchen display system, reservations, inventory management, QR ordering, and bookkeeping. With its unique pricing model and commitment to merchant success, Tebi is dedicated to empowering hospitality businesses everywhere. To learn more about adopting Tebi for your business, visit www.tebi.com.
Tebi is currently hiring across all functions, including engineering, product management and operations in both Amsterdam and London. Visit Tebi’s careers page to see all open positions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250610225196/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom